Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Barriers to Prostate Cancer Research in Black Men Identified
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — A lack of understanding of terminology, health care system distrust, and a lack of prostate cancer knowledge are among the barriers to genomic testing for prostate cancer and prostate cancer research participation among black men, according to a study published in the November issue of the American Journal of Preventive Medicine.
Link Between Statins, Non-CVD Outcomes Lacks Evidence
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — There is a lack of convincing evidence for an association between statin use and non-cardiovascular disease (CVD) outcomes, according to a review published in the Oct. 16 issue of the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Genetic Risk Score IDs Breast CA Risk in Female Child CA Survivors
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — A polygenic risk score (PRS) can identify subsequent breast cancer risk among childhood survivors of cancer, according to a study published online Oct. 26 in Clinical Cancer Research.
Abstract/Full Text (subscription or payment may be required)
Black, Low-Income Women May Not Report Barriers to Care
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — Black women, women living in poverty, and those with higher levels of distrust are less likely to report barriers to timely screening mammography, according to a study published online Sept. 24 in Cancer.
Abstract
Full Text (subscription or payment may be required)
Erectile Dysfunction Common in Childhood Cancer Survivors
TUESDAY, Oct. 30, 2018 (HealthDay News) — The prevalence of erectile dysfunction (ED) is 29 percent among male childhood cancer survivors (CCS), according to a research letter published online Oct. 4 in JAMA Oncology.
Abstract/Full Text (subscription or payment may be required)
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk
TUESDAY, Oct. 30, 2018 (HealthDay News) — The use of angiotensin-converting enzyme inhibitors (ACEIs) is associated with an increased risk for lung cancer compared with angiotensin receptor blockers, according to a study published online Oct. 24 in the BMJ.
Pilot Studies May Shed Light on How to Treat Lymphedema
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Risk for Ischemic Stroke Increased After Cancer Diagnosis 
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S. 
Cancer Risk ID"d for Asian American, NHPI Population 
Residential Context Has Larger Impact on Ovarian Cancer Survival in Black Women 
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Couples" Coping Skills Help Reduce Depression in GI Cancer Survivors .jpg)
